CCR2 and neoplasm: The cohort that received intratumor CCR2+HSCs had endogenous T cells isolated from tumor draining lymph nodes that mounted the capacity to recognize Ptc tumor cells, secreting IFNγ upon co-culture against Ptc tumor cell targets (Fig. 5c).